Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
MATERIAL SCIENCES CORP (MASC)
|
Add to portfolio |
|
|
|
| Price: |
$7.97
| | Metrics |
| OS: |
10.3
|
M
| |
5
|
% ROE
|
| Market cap: |
$82.3
|
M
| |
-1
|
% ROIC
|
|
Net cash:
|
$38.3
|
M
| |
$3.71
|
per share
|
|
EV:
|
$44
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$3.6
|
M
| |
12.4
|
x EV/EBITDA
|
|
EBIT
|
($488.0)
|
k
| |
|
|
| EPS |
$0.46
| |
17.3
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Feb-28-13 | Feb-29-12 | Feb-28-11 | Feb-28-10 | Feb-28-09 | Feb-28-08 | Feb-28-07 | Feb-28-06 |
| Revenues | 121.0 | 136.7 | 137.6 | 137.8 | 187.0 | 235.0 | 262.6 | 286.6 |
| Revenue growth | -11.5% | -0.6% | -0.1% | -26.3% | -20.4% | -10.5% | -8.4% | 8.8% |
| Cost of goods sold | 92.5 | 103.1 | 105.9 | 121.7 | 175.9 | 210.7 | 220.7 | 235.8 |
| Gross profit | 28.5 | 33.7 | 31.7 | 16.1 | 11.1 | 24.3 | 41.9 | 50.8 |
| Gross margin | 23.6% | 24.6% | 23.0% | 11.7% | 5.9% | 10.3% | 15.9% | 17.7% |
| Selling, general and administrative | 20.0 | 21.1 | 22.6 | 26.5 | 33.9 | 36.5 | 33.7 | 36.7 |
| EBIT | 8.8 | 12.0 | 5.8 | -10.4 | -22.8 | -12.2 | 8.2 | 14.0 |
| EBIT margin | 7.2% | 8.8% | 4.2% | -7.6% | -12.2% | -5.2% | 3.1% | 4.9% |
| Pre-tax income | 12.6 | 13.6 | 12.4 | -11.7 | -25.6 | -10.8 | 8.7 | 14.2 |
| Income taxes | 3.6 | -14.9 | 0.3 | -0.1 | 7.5 | -4.4 | 2.4 | 7.0 |
| Tax rate | 28.7% | | 2.6% | 0.7% | | 40.3% | 27.8% | 48.9% |
| Earnings from continuing ops | 9.0 | 28.5 | 12.0 | -11.6 | -33.1 | -6.5 | 6.3 | 7.3 |
| Earnings from discontinued ops | | | | | | | | 0.0 |
| Net income | 9.0 | 28.5 | 12.0 | -11.6 | -33.1 | -6.5 | 6.3 | 5.3 |
| Net margin | 7.4% | 20.8% | 8.8% | -8.4% | -17.7% | -2.8% | 2.4% | 1.8% |
| |
| Diluted EPS | $0.86 | $2.49 | $0.93 | ($0.89) | ($2.41) | ($0.45) | $0.43 | $0.50 |
| Shares outstanding (diluted) | 10.4 | 11.4 | 13.0 | 13.0 | 13.7 | 14.4 | 14.6 | 14.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|